| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN)
ASLN Technical Analysis
5
| As on 9th Jun 2023 ASLN STOCK Price closed @ 3.78 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.69 & Strong Buy for SHORT-TERM with Stoploss of 0.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ASLNSTOCK Price
| Open | 3.80 | Change | Price | % |
| High | 3.89 | 1 Day | -0.06 | -1.56 |
| Low | 3.70 | 1 Week | -0.22 | -5.50 |
| Close | 3.78 | 1 Month | -0.47 | -11.06 |
| Volume | 47730 | 1 Year | 2.58 | 215.00 |
| 52 Week High 4.59 | 52 Week Low 0.36 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ASLN Daily Charts |
ASLN Intraday Charts |
Whats New @ Bazaartrend |
ASLN Free Analysis |
|
|
ASLN Important Levels Intraday
| RESISTANCE | 4.15 |
| RESISTANCE | 4.03 |
| RESISTANCE | 3.96 |
| RESISTANCE | 3.88 |
| SUPPORT | 3.68 |
| SUPPORT | 3.60 |
| SUPPORT | 3.53 |
| SUPPORT | 3.41 |
ASLN Forecast April 2024
| 4th UP Forecast | 4.45 |
| 3rd UP Forecast | 4.24 |
| 2nd UP Forecast | 4.1 |
| 1st UP Forecast | 3.97 |
| 1st DOWN Forecast | 3.59 |
| 2nd DOWN Forecast | 3.46 |
| 3rd DOWN Forecast | 3.32 |
| 4th DOWN Forecast | 3.11 |
ASLN Weekly Forecast
| 4th UP Forecast | 4.13 |
| 3rd UP Forecast | 4.02 |
| 2nd UP Forecast | 3.95 |
| 1st UP Forecast | 3.88 |
| 1st DOWN Forecast | 3.68 |
| 2nd DOWN Forecast | 3.61 |
| 3rd DOWN Forecast | 3.54 |
| 4th DOWN Forecast | 3.43 |
ASLN Forecast2024
| 4th UP Forecast | 12.16 |
| 3rd UP Forecast | 9.47 |
| 2nd UP Forecast | 7.81 |
| 1st UP Forecast | 6.15 |
| 1st DOWN Forecast | 1.41 |
| 2nd DOWN Forecast | -0.25 |
| 3rd DOWN Forecast | -1.91 |
| 4th DOWN Forecast | -4.6 |
ASLAN Pharmaceuticals Limited ( NASDAQ USA Symbol : ASLN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ASLN Business Profile
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore. Address: 83 Clemenceau Avenue, Singapore, Singapore, 239920
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service